Seaport Therapeutics
Seaport Therapeutics is seeking an Associate Director, Program Management to lead integrated planning and execution for a clinical-stage neuropsychiatric program. The role partners with cross‑functional teams—including Clinical Development, Clinical Operations, Regulatory, Technical Operations (CMC), and Nonclinical Development—to develop timelines, manage risks, and ensure program milestones are met, while also standardizing program management tools and processes across the portfolio.
Seaport Therapeutics is a biotechnology company developing novel neuropsychiatric medicines. The company applies its Glyph platform to advance potentially best-in-class therapeutics designed to improve efficacy and tolerability for patients with depression, anxiety, and other neuropsychiatric disorders.
Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function
2 weeks ago
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 5, 2026
Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Seaport Therapeutics.
13% below the average for this role
Associate Director, Program Management
Structure Therapeutics
Program Manager, CMC Development
alnylam
Manager, CMC Project Management
Crescent Biopharma
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
Sr. Clinical Program Manager-Endocrinology
lifelancer
Sr. Clinical Program Manager
Neurocrine Biosciences